Act Capital Management, LLC Karyopharm Therapeutics Inc. Put Options Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KPTI
# of Institutions
48Shares Held
38.1MCall Options Held
437KPut Options Held
43.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$44.8 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$34.8 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$29.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.51MShares$24.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.1MShares$22 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $566M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...